Lilly finds impurity in compounded version of its weight-loss drug, warns of health risksReuters • 03/12/26
India warns drugmakers against direct or surrogate weight-loss drug and obesity adsReuters • 03/11/26
Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market?The Motley Fool • 03/06/26
Lilly (LLY) Down 3.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/06/26
Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts SuppliesSeeking Alpha • 03/06/26
Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear?Zacks Investment Research • 03/05/26
Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patientsPRNewsWire • 03/05/26